Does ATEZOLIZUMAB Cause Mucosal inflammation? 205 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 205 reports of Mucosal inflammation have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 0.6% of all adverse event reports for ATEZOLIZUMAB.
205
Reports of Mucosal inflammation with ATEZOLIZUMAB
0.6%
of all ATEZOLIZUMAB reports
78
Deaths
134
Hospitalizations
How Dangerous Is Mucosal inflammation From ATEZOLIZUMAB?
Of the 205 reports, 78 (38.0%) resulted in death, 134 (65.4%) required hospitalization, and 21 (10.2%) were considered life-threatening.
Is Mucosal inflammation Listed in the Official Label?
Yes, Mucosal inflammation is listed as a known adverse reaction in the official FDA drug label for ATEZOLIZUMAB.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Mucosal inflammation?
METHOTREXATE (3,352)
CYCLOPHOSPHAMIDE (2,535)
DOXORUBICIN (1,939)
VINCRISTINE (1,594)
ETOPOSIDE (1,591)
FLUOROURACIL (1,481)
RITUXIMAB (1,364)
CYTARABINE (1,337)
CAPECITABINE (1,262)
CARBOPLATIN (1,259)
Which ATEZOLIZUMAB Alternatives Have Lower Mucosal inflammation Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN